BIO Professional Development
Through a curated network of education alliance partners, BIO offers industry professionals executive training and development resources for accelerating career growth
Scientific Exchange/Safe Harbor
Overview of key elements of scientific exchange based on several FDA guidance documents including responding to unsolicited requests for off-label information about prescription drugs and medical devices and distributing scientific and medical publications on unapproved new uses – recommended practices. Covers range of activities including definition of scientific exchange and safe harbor, general guidelines for compliant content, responding to unsolicited questions for off-label, and distribution of scientific and medical publications on unapproved new uses.
Takeaways
- Scientific Exchange is an FDA regulation that is codified in the Code of Federal Regulations, or CFR, as Section 312.7(a)
- Scientific exchange occurs when companies exchange medical and scientific information or data in a non-promotional context, or in response to unsolicited questions from healthcare professionals, healthcare organizations, patient advocacy groups, and third party media
- When this exchange is non-promotional in nature, it is regarded as acceptable from an enforcement standpoint and is known unofficially as a “safe harbor.”
- The FDA has issued several guidances relating to scientific exchange/safe harbor, including responding to unsolicited questions for off-label, and distribution of scientific and medical publications on unapproved new uses
Course offered by
Course Price:
$200 USD
BIO Member Price:
$160 USD
Course Length:
30 minutes
Course Level:
Introductory
Course Format:
On-Demand